Fibrin-mediated lentivirus gene transfer: Implications for lentivirus microarrays

Journal of Controlled Release

Volumn 144, Issue 2, 2010, Pages 213-220

  Raut, Shruti D ^a   Lei, Pedro ^a   Padmashali, Roshan M ^a   Andreadis, Stelios T ^a,b  

^a State University of New York ^*  (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cell controlled gene delivery; Fibrin hydrogels; Fibrinolysis; Lentiviral microarrays; Matrix mediated transduction

Indexed keywords

FIBRIN HYDROGELS; FIBRINOLYSIS; GENE DELIVERY; MATRIX; MATRIX-MEDIATED TRANSDUCTION;

BACTERIOPHAGES; CONCENTRATION (PROCESS); DEGRADATION; GELS; HYDROGELS;

GENE TRANSFER;

FIBRIN; FIBRINOGEN; HEXADIMETHRINE BROMIDE; LENTIVIRUS VECTOR;

ARTICLE; CONTAMINATION; CONTROLLED STUDY; DNA MICROARRAY; FIBRINOLYSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSDUCTION; HYDROGEL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; VIRAL GENE DELIVERY SYSTEM;

FIBRIN; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES; HUMANS; LENTIVIRUS;

EID: 77952673515     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.02.009     Document Type: Article

References (53)

1. Luten J., van Nostrum C.F., De Smedt S.C., Hennink W.E. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Control. Release 2008, 126:97-110.
2. Segura T., Shea L.D. Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug. Chem. 2002, 13:621-629.
3. Bengali Z., Rea J.C., Shea L.D. Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density. J. Gene Med. 2007, 9:668-678.
4. Trentin D., Hubbell J., Hall H. Non-viral gene delivery for local and controlled DNA release. J. Control. Release 2005, 102:263-275.
5. Kim T.I., Ou M., Lee M., Kim S.W. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 2009, 30:658-664.
6. Lei P., Padmashali R.M., Andreadis S.T. Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 2009, 30:3790-3799.
7. Schillinger U., Wexel G., Hacker C., Kullmer M., Koch C., Gerg M., Vogt S., Ueblacker P., Tischer T., Hensler D., Wilisch J., Aigner J., Walch A., Stemberger A., Plank C. A fibrin glue composition as carrier for nucleic acid vectors. Pharm. Res. 2008, 25:2946-2962.
8. des Rieux A., Shikanov A., Shea L.D. Fibrin hydrogels for non-viral vector delivery in vitro. J. Control. Release 2009, 136:148-154.
9. Kulkarni M., Breen A., Greiser U., O'Brien T., Pandit A. Fibrin-lipoplex system for controlled topical delivery of multiple genes. Biomacromolecules 2009, 10:1650-1654.
10. Chandler L.A., Doukas J., Gonzalez A.M., Hoganson D.K., Gu D.L., Ma C., Nesbit M., Crombleholme T.M., Herlyn M., Sosnowski B.A., Pierce G.F. FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol. Ther. 2000, 2:153-160.
11. Doukas J., Blease K., Craig D., Ma C., Chandler L.A., Sosnowski B.A., Pierce G.F. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol. Ther. 2002, 5:517-527.
12. Schek R.M., Hollister S.J., Krebsbach P.H. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol. Ther. 2004, 9:130-138.
13. Teraishi F., Umeoka T., Saito T., Tsukagoshi T., Tanaka N., Fujiwara T. A novel method for gene delivery and expression in esophageal epithelium with fibrin glues containing replication-deficient adenovirus vector. Surg. Endosc. 2003, 17:1845-1848.
14. Breen A., Dockery P., O'Brien T., Pandit A. Fibrin scaffold promotes adenoviral gene transfer and controlled vector delivery. J. Biomed. Mater. Res. A 2009, 89:876-884.
15. Escamez M.J., Carretero M., Garcia M., Martinez-Santamaria L., Mirones I., Duarte B., Holguin A., Garcia E., Garcia V., Meana A., Jorcano J.L., Larcher F., Del Rio M. Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancement. J. Invest. Dermatol. 2008, 128:1565-1575.
16. Breen A.M., Dockery P., O'Brien T., Pandit A.S. The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. Biomaterials 2008, 29:3143-3151.
17. Nasu T., Ito H., Tsutsumi R., Kitaori T., Takemoto M., Schwarz E.M., Nakamura T. Biological activation of bone-related biomaterials by recombinant adeno-associated virus vector. J. Orthop. Res. 2009, 27:1162-1168.
18. Silva J.M., Mizuno H., Brady A., Lucito R., Hannon G.J. RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6548-6552.
19. Bhattacharya B., Cai J., Luo Y., Miura T., Mejido J., Brimble S.N., Zeng X., Schulz T.C., Rao M.S., Puri R.K. Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev. Biol. 2005, 5:22.
20. Anderson D.G., Putnam D., Lavik E.B., Mahmood T.A., Langer R. Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials 2005, 26:4892-4897.
21. Nimrichter L., Gargir A., Gortler M., Altstock R.T., Shtevi A., Weisshaus O., Fire E., Dotan N., Schnaar R.L. Intact cell adhesion to glycan microarrays. Glycobiology 2004, 14:197-203.
22. Belov M.E., Rakov V.S., Nikolaev E.N., Goshe M.B., Anderson G.A., Smith R.D. Initial implementation of external accumulation liquid chromatography/electrospray ionization Fourier transform ion cyclotron resonance with automated gain control. Rapid Commun. Mass Spectrom. 2003, 17:627-636.
23. Ko I.K., Kato K., Iwata H. Antibody microarray for correlating cell phenotype with surface marker. Biomaterials 2005, 26:687-696.
24. Bailey R.E., Smith A.M., Nie S. Quantum dots in biology and medicine. Physica E 2004, 25:1.
25. Angres B. Cell microarrays. Expert Rev. Mol. Diagn. 2005, 5:769-779.
26. Castel D., Pitaval A., Debily M.A., Gidrol X. Cell microarrays in drug discovery. Drug Discov. Today 2006, 11:616-622.
27. Bailey S.N., Ali S.M., Carpenter A.E., Higgins C.O., Sabatini D.M. Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat. Methods 2006, 3:117-122.
28. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., Carpenter A.E., Foo S.Y., Stewart S.A., Stockwell B.R., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M., Root D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298.
29. Tian J., Andreadis S.T. Independent and high-level dual-gene expression in adult stem-progenitor cells from a single lentiviral vector. Gene Ther. 2009, 16:874-884.
30. Lei P., Bajaj B., Andreadis S.T. Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin. J. Virol. 2002, 76:8722-8728.
31. Lei P., Andreadis S.T. Stoichiometric limitations in assembly of active recombinant retrovirus. Biotechnol. Bioeng. 2005, 90:781-792.
32. Herbert C.B., Nagaswami C., Bittner G.D., Hubbell J.A., Weisel J.W. Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. J. Biomed. Mater. Res. 1998, 40:551-559.
33. Toyoshima K., Vogt P.K. Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 1969, 38:414-426.
34. Andreadis S., Palsson B.O. Coupled effects of polybrene and calf serum on the efficiency of retroviral transduction and the stability of retroviral vectors. Hum. Gene Ther. 1997, 8:285-291.
35. Davis H.E., Morgan J.R., Yarmush M.L. Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys. Chem. 2002, 97:159-172.
36. Bajaj B., Lei P., Andreadis S.T. High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization. Biotechnol. Prog. 2001, 17:587-596.
37. Bannasch H., Fohn M., Unterberg T., Bach A.D., Weyand B., Stark G.B. Skin tissue engineering. Clin. Plast. Surg. 2003, 30:573-579.
38. Geer D.J., Andreadis S.T. A novel role of fibrin in epidermal healing: plasminogen-mediated migration and selective detachment of differentiated keratinocytes. J. Invest. Dermatol. 2003, 121:1210-1216.
39. Geer D.J., Swartz D.D., Andreadis S.T. Fibrin promotes migration in a three-dimensional in vitro model of wound regeneration. Tissue Eng. 2002, 8:787-798.
40. Grassl E.D., Oegema T.R., Tranquillo R.T. A fibrin-based arterial media equivalent. J. Biomed. Mater. Res. 2003, 66A:550-561.
41. Isenberg B.C., Williams C., Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ. Res. 2006, 98:25-35.
42. Swartz D.D., Russell J.A., Andreadis S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am. J. Physiol. Heart Circ Physiol. 2005, 288:H1451-H1460. Electronic publication 2004 Oct 1414.
43. Liu J.Y., Swartz D.D., Peng H.F., Gugino S.F., Russell J.A., Andreadis S.T. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc. Res. 2007, 75:618-628.
44. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Control. Release 2001, 72:101-113.
45. Geer D.J., Swartz D.D., Andreadis S.T. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. Am. J. Pathol. 2005, 167:1575-1586.
46. Pandit A.S., Wilson D.J., Feldman D.S. Fibrin scaffold as an effective vehicle for the delivery of acidic fibroblast growth factor (FGF-1). J. Biomater. Appl. 2000, 14:229-242.
47. Sakiyama S.E., Schense J.C., Hubbell J.A. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J. 1999, 13:2214-2224.
48. Sakiyama-Elbert S.E., Hubbell J.A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J. Control. Release 2000, 69:149-158.
49. Sakiyama-Elbert S.E., Panitch A., Hubbell J.A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 2001, 15:1300-1302.
50. Mannucci P.M. Hemostatic drugs. N. Engl. J. Med. 1998, 339:245-253.
51. Andreadis S., Brott D.A., Fuller A.O., Palsson B.O. Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J. Virol. 1997, 71:7541-7548.
52. Andreadis S., Lavery T., Davis H.E., Le Doux J.M., Yarmush M.L., Morgan J.R. Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection. J. Virol. 2000, 74:3431-3439.
53. Kubo M., Van de Water L., Plantefaber L.C., Mosesson M.W., Simon M., Tonnesen M.G., Taichman L., Clark R.A. Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J. Invest. Dermatol. 2001, 117:1369-1381.